伊朗的人类皮肤利什曼病,截至 2019 年。

Pub Date : 2021-06-30 eCollection Date: 2021-06-01 DOI:10.18502/jad.v15i2.7483
Mohamad Reza Razavi, Mohammad Reza Shirzadi, Mehdi Mohebali, Mohammad Reza Yaghoobi-Ershadi, Hassan Vatandoost, Mehrshad Shirzadi, Mohammad Mehdi Gouya, Faranak Gharachorloo, Shahnam Arshi, Behzad Amiri
{"title":"伊朗的人类皮肤利什曼病,截至 2019 年。","authors":"Mohamad Reza Razavi, Mohammad Reza Shirzadi, Mehdi Mohebali, Mohammad Reza Yaghoobi-Ershadi, Hassan Vatandoost, Mehrshad Shirzadi, Mohammad Mehdi Gouya, Faranak Gharachorloo, Shahnam Arshi, Behzad Amiri","doi":"10.18502/jad.v15i2.7483","DOIUrl":null,"url":null,"abstract":"<p><p>Cutaneous leishmaniasis is a neglected and parasitic vector borne diseases that is endemic in tropical and subtropical countries, including Iran. The aim of this study was to explain the present status of CL in Iran. This report is based on data that recorded by cutaneous leishmaniasis surveillance system in 2019, and evaluated in Center for Communicable Diseases Management in Ministry of Health in Iran. Iran has been considered an endemic area for cutaneous leishmaniasis in the world. Dependent to activities for cutaneous leishmaniasis control the number of cases decreased from 23202 in 2008 (Incidence rate 32 per 100000) to 13124 in 2019 (Incidence rate 15.8 per 100000), more cases reported from September to December, in 2019, 46% of cases had one lesion and 21% had 2 lesions, 85% of cases diagnosed when the diameter of lesions had 3 centimeters and bellows. Although the <i>Leishmania</i> control program began in 1977, the incidence of the disease has dropped dramatically since 2008 when the new cutaneous leishmaniasis control program have been implemented. Although in some areas the incidence of the disease increased, but the implementation of the new program has reduced the number of cases, in order to continue reducing the disease, permanent support for the control programs is needed.</p>","PeriodicalId":0,"journal":{"name":"","volume":null,"pages":null},"PeriodicalIF":0.0,"publicationDate":"2021-06-30","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://ftp.ncbi.nlm.nih.gov/pub/pmc/oa_pdf/db/8e/JAD-15-143.PMC8782751.pdf","citationCount":"0","resultStr":"{\"title\":\"Human Cutaneous Leishmaniosis in Iran, Up to Date-2019.\",\"authors\":\"Mohamad Reza Razavi, Mohammad Reza Shirzadi, Mehdi Mohebali, Mohammad Reza Yaghoobi-Ershadi, Hassan Vatandoost, Mehrshad Shirzadi, Mohammad Mehdi Gouya, Faranak Gharachorloo, Shahnam Arshi, Behzad Amiri\",\"doi\":\"10.18502/jad.v15i2.7483\",\"DOIUrl\":null,\"url\":null,\"abstract\":\"<p><p>Cutaneous leishmaniasis is a neglected and parasitic vector borne diseases that is endemic in tropical and subtropical countries, including Iran. The aim of this study was to explain the present status of CL in Iran. This report is based on data that recorded by cutaneous leishmaniasis surveillance system in 2019, and evaluated in Center for Communicable Diseases Management in Ministry of Health in Iran. Iran has been considered an endemic area for cutaneous leishmaniasis in the world. Dependent to activities for cutaneous leishmaniasis control the number of cases decreased from 23202 in 2008 (Incidence rate 32 per 100000) to 13124 in 2019 (Incidence rate 15.8 per 100000), more cases reported from September to December, in 2019, 46% of cases had one lesion and 21% had 2 lesions, 85% of cases diagnosed when the diameter of lesions had 3 centimeters and bellows. Although the <i>Leishmania</i> control program began in 1977, the incidence of the disease has dropped dramatically since 2008 when the new cutaneous leishmaniasis control program have been implemented. Although in some areas the incidence of the disease increased, but the implementation of the new program has reduced the number of cases, in order to continue reducing the disease, permanent support for the control programs is needed.</p>\",\"PeriodicalId\":0,\"journal\":{\"name\":\"\",\"volume\":null,\"pages\":null},\"PeriodicalIF\":0.0,\"publicationDate\":\"2021-06-30\",\"publicationTypes\":\"Journal Article\",\"fieldsOfStudy\":null,\"isOpenAccess\":false,\"openAccessPdf\":\"https://ftp.ncbi.nlm.nih.gov/pub/pmc/oa_pdf/db/8e/JAD-15-143.PMC8782751.pdf\",\"citationCount\":\"0\",\"resultStr\":null,\"platform\":\"Semanticscholar\",\"paperid\":null,\"PeriodicalName\":\"\",\"FirstCategoryId\":\"3\",\"ListUrlMain\":\"https://doi.org/10.18502/jad.v15i2.7483\",\"RegionNum\":0,\"RegionCategory\":null,\"ArticlePicture\":[],\"TitleCN\":null,\"AbstractTextCN\":null,\"PMCID\":null,\"EPubDate\":\"2021/6/1 0:00:00\",\"PubModel\":\"eCollection\",\"JCR\":\"\",\"JCRName\":\"\",\"Score\":null,\"Total\":0}","platform":"Semanticscholar","paperid":null,"PeriodicalName":"","FirstCategoryId":"3","ListUrlMain":"https://doi.org/10.18502/jad.v15i2.7483","RegionNum":0,"RegionCategory":null,"ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"2021/6/1 0:00:00","PubModel":"eCollection","JCR":"","JCRName":"","Score":null,"Total":0}
引用次数: 0

摘要

皮肤利什曼病是一种被忽视的寄生病媒传染病,在包括伊朗在内的热带和亚热带国家流行。本研究旨在解释伊朗的皮肤利什曼病现状。本报告基于 2019 年皮肤利什曼病监测系统记录的数据,并由伊朗卫生部传染病管理中心进行评估。伊朗一直被认为是世界上皮肤利什曼病流行的地区。由于开展了皮肤利什曼病控制活动,病例数从2008年的23202例(发病率为每10万人32例)下降到2019年的13124例(发病率为每10万人15.8例),2019年9月至12月报告的病例较多,46%的病例有一个皮损,21%的病例有两个皮损,85%的病例在皮损直径为3厘米和波纹管时被确诊。虽然利什曼病控制计划始于1977年,但自2008年新的皮肤利什曼病控制计划实施以来,该病的发病率已大幅下降。虽然某些地区的发病率有所上升,但新计划的实施减少了病例数量,为了继续减少该疾病,需要对控制计划提供长期支持。
本文章由计算机程序翻译,如有差异,请以英文原文为准。

Human Cutaneous Leishmaniosis in Iran, Up to Date-2019.

Human Cutaneous Leishmaniosis in Iran, Up to Date-2019.

Human Cutaneous Leishmaniosis in Iran, Up to Date-2019.

分享
查看原文
Human Cutaneous Leishmaniosis in Iran, Up to Date-2019.

Cutaneous leishmaniasis is a neglected and parasitic vector borne diseases that is endemic in tropical and subtropical countries, including Iran. The aim of this study was to explain the present status of CL in Iran. This report is based on data that recorded by cutaneous leishmaniasis surveillance system in 2019, and evaluated in Center for Communicable Diseases Management in Ministry of Health in Iran. Iran has been considered an endemic area for cutaneous leishmaniasis in the world. Dependent to activities for cutaneous leishmaniasis control the number of cases decreased from 23202 in 2008 (Incidence rate 32 per 100000) to 13124 in 2019 (Incidence rate 15.8 per 100000), more cases reported from September to December, in 2019, 46% of cases had one lesion and 21% had 2 lesions, 85% of cases diagnosed when the diameter of lesions had 3 centimeters and bellows. Although the Leishmania control program began in 1977, the incidence of the disease has dropped dramatically since 2008 when the new cutaneous leishmaniasis control program have been implemented. Although in some areas the incidence of the disease increased, but the implementation of the new program has reduced the number of cases, in order to continue reducing the disease, permanent support for the control programs is needed.

求助全文
通过发布文献求助,成功后即可免费获取论文全文。 去求助
×
引用
GB/T 7714-2015
复制
MLA
复制
APA
复制
导出至
BibTeX EndNote RefMan NoteFirst NoteExpress
×
提示
您的信息不完整,为了账户安全,请先补充。
现在去补充
×
提示
您因"违规操作"
具体请查看互助需知
我知道了
×
提示
确定
请完成安全验证×
copy
已复制链接
快去分享给好友吧!
我知道了
右上角分享
点击右上角分享
0
联系我们:info@booksci.cn Book学术提供免费学术资源搜索服务,方便国内外学者检索中英文文献。致力于提供最便捷和优质的服务体验。 Copyright © 2023 布克学术 All rights reserved.
京ICP备2023020795号-1
ghs 京公网安备 11010802042870号
Book学术文献互助
Book学术文献互助群
群 号:481959085
Book学术官方微信